Roy Morgan is an innovation driver in the medical device industry known for inventing the first orthopedic device to upregulate genetic compounds and speed healing in osteoarthritis patients. He has strong skills in R&D, regulatory approval, intellectual property, and project management. Morgan has successfully launched multiple medical devices in companies like Abbott Laboratories and Stryker, with his products generating over $100 million in revenue. He is published in scientific journals and applies a leadership approach focused on strengths-based talent evaluation and uncommon team performance.